Rallybio Corp (RLYB) Social Stream



Rallybio Corp (RLYB): $14.47

0.01 (+0.07%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RLYB to Watchlist
Sign Up

Industry: Biotech


Ranked

of 384

in industry

RALLYBIO CORP (RLYB) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering RALLYBIO CORP.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 3 $40 $20 $30 $13.39 124.05%
2022-08-08 4 $40 $20 $30.666 $13.39 129.02%
2022-08-09 3 $34 $20 $27 $13.39 101.64%

The Trend in the Analyst Price Target


RLYB's average price target has moved up $1.33 over the prior 48 weeks.

Over the past 39 weeks, RLYB's average upside potential has been 162.74%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-10 3 40 20 30.000 19.91 50.68%
2022-02-22 4 40 20 30.666 11.74 161.21%
2022-03-15 4 40 20 30.666 8.64 254.93%
2022-08-09 3 40 20 31.333 10.29 204.5%
2022-08-09 4 34 20 27.000 10.29 162.39%

RLYB Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 26 weeks, RLYB's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, RALLYBIO CORP's number of analysts covering the stock is greater than 91.22% of them.
  • RALLYBIO CORP's variance in analysts' estimates is lower than -321.54% of all US stocks.
  • RLYB has a greater average analyst price target than 419.04% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, RALLYBIO CORP's upside potential (average analyst target price relative to current price) is higher than 204.28% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to RALLYBIO CORP are RLMD, RIGL, and RGLS.

Is RLYB a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4278 seconds.